Clinical target volume delineation in glioblastomas: Pre-operative versus post-operative/pre-radiotherapy MRI

British Journal of Radiology

Volumn 84, Issue 999, 2011, Pages 271-278

  Farace, Paolo ^a   Giri, M G ^b   Meliado G ^b   Amelio, D ^c   Widesott, L ^c   Ricciardi, G K ^b   Dall'Oglio, S ^b   Rizzotti, A ^b   Sbarbati, A ^a   Beltramello, A ^b   Maluta, S ^b   Amichetti, M ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b BORGO TRENTO HOSPITAL   (Italy)

^c ATreP   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CRANIECTOMY; DISEASE COURSE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; TREATMENT PLANNING;

BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OBSERVER VARIATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 79951939321     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/10315979     Document Type: Article

References (35)

1. Stupp R, Hegi ME, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 2007;25:4127-36. (Pubitemid 47492957)
2. Laperriere N, Zuraw L, Cairncross G. Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002;64:259-73.
3. Baumert BG, Brada M, Bernier J, Kortmann RD, Dehing-Oberije C, Collette L, et al. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and qualityassurance results of the stereotactic boost arm. Radiother Oncol 2008;88:163-72.
4. Buatti J, Ryken TC, Smith MC, Sneed P, Suh JH, Mehta M, et al. Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol 2008;89:313-37.
5. Mason WP, Maestro RD, Eisenstat D, Forsyth P, Fulton D, Laperrière N, et al. Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol 2007;14:110-17. (Pubitemid 47204238)
6. Frappaz D, Chinot O, Bataillard A, Ben Hassel M, Capelle L, Chanalet S, et al. Summary version of the standards, options and recommendations for the management of adult patients with intracranial glioma. Br J Cancer 2003;89:S73-83.
7. RTOG 0825. Available from: http://www.rtog.org/members/active.html#brain.
8. EORTC protocol 26082-22081. Available from: www.eortc.be/protoc/listprot. asp?kind5group&grp51.
9. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002;20:1635-42. (Pubitemid 34260545)
10. Aydin H, Sillenberg I, von Lieven H. Patterns of failure following CT-based 3-D irradiation for malignant glioma. Strahlenther Onkol 2001;177:424-31. (Pubitemid 32756556)
11. Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys 2007;68:144-50. (Pubitemid 46589839)
12. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M. 3Drecurrence-patterns of glioblastomas after CT-planned postoperative irradiation. Radiother Oncol 1999;53:53-7.
13. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30:907-11. (Pubitemid 10059239)
14. Duchstein S, Gademann G, Peters B. Early and late effects of local high dose radiotherapy of the brain on memory and attention. Strahlenther Onkol 2003;179:441-51. (Pubitemid 36735772)
15. Archibald YM, Lunn D, Ruttan LA, Macdonald DR, Del Maestro RF, Barr HW, et al. Cognitive functioning in longterm survivors of high grade glioma. J Neurosurg 1994;80:247-253. (Pubitemid 24036495)
16. Bosma I, Vos MJ, Heimans JJ, Taphoorn MJ, Aaronson NK, Postma TJ, et al. The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol 2007;9:53-62. (Pubitemid 46543489)
17. Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol 1991;12:45-62.
18. Burger PC, Mahaley MS, Dudka L, Vogel FS. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a post-mortem study of 25 cases. Cancer 1979;44:1256-72. (Pubitemid 10197395)
19. Steen RG, Spence D, Wu S, Xiong X, Kun LE, Merchant TE. Effect of therapeutic ionizing radiation on the human brain. Ann Neurol 2001;50:787-95. (Pubitemid 33116139)
20. Narayana A, Chang J, Thakur S, Huang W, Karimi S, Hou B, et al. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol 2007;80:347-54. (Pubitemid 47315848)
21. Kuczer D, Feussner A, Wurm R, Wust P, Michel R, Stockhammer F, et al. 123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study. Br J Radiol 2007;80:274-8. (Pubitemid 47018381)
22. McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002;97:794-802. (Pubitemid 35222399)
23. Croteau D, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rock JP, et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 2001;49:823-9. (Pubitemid 32927953)
24. Price SJ, Jena R, Burnet NG, Hutchinson PJ, Dean AF, Peña A, et al. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. AJNR Am J Neuroradiol 2006;27:1969-74. (Pubitemid 44556519)
25. Park I, Tamai G, Lee MC, Chuang CF, Chang SM, Berger MS, et al. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings. Int J Radiat Oncol Biol Phys 2007;69:381-9. (Pubitemid 47380095)
26. Laprie A, Catalaa I, Cassol E,McKnight TR, Berchery D, Marre D, et al. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2008;70:773-81. (Pubitemid 351199728)
27. Krishnan AP, Asher IM, Davis D, Okunieff P, O'Dell WG. Evidence that MR diffusion tensor imaging (tractography) predicts the natural history of regional progression in patients irradiated conformally for primary brain tumors. Int J Radiat Oncol Biol Phys 2008;71:1553-62.
28. Kracht LW, Miletic H, Busch S, Jacobs AH, Voges J, Hoevels M, et al. Delineation of brain tumor extent with [11C]Lmethionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 2004;10:7163-70.
29. Lee IH, Piert M, Gomez-Hassan D, Junck L, Rogers L, Hayman J, et al. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2009;73:479-85.
30. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450-9. (Pubitemid 17084816)
31. Halperin EC, Bentel G, Heinz ER, Burger PC. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989;17:1347-50. (Pubitemid 20028658)
32. Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, et al. Improved delineation of brain tumours: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. Neuroimage 2004;23:454-61. (Pubitemid 39370597)
33. Ganslandt O, Stadlbauer A, Fahlbusch R, Kamada K, Buslei R, Blumcke I, et al. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumour cell density. Neurosurgery 2005;56:291-8.
34. Pennington C, Kilbride L, Grant R, Wardlaw JM. A pilot study of brain tumour growth between radiotherapy planning and delivery. Clin Oncol (R Coll Radiol) 2006;18:104-8. (Pubitemid 43169137)
35. Tsien C, Gomez-Hassan D, Ten Haken RK, Tatro D, Junck L, Chenevert TL, et al. Evaluating changes in tumour volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys 2005;62:328-32. (Pubitemid 40704446)